This notion is supported even further by our recent findings, where we have shown that WBC miR-126 levels were considerably higher in CF BRCA1-methylation carriers than in age-matched controls, which was consistent with the findings in patients with BC and OC [39]. This evidence concerns the gene BRCA1 and cystic fibrosis.